Outbreaks of infection with multi-resistant microorganisms are an increasing problem in intensive care units. Such outbreaks lead to increased mortality, longer duration of stay, higher costs and reduced availability of ICU beds [1, 2]. Many guidelines advocate strict adherence to hygiene measures, patient isolation and antibiotic restriction, but in spite of good and sometimes even supervised adherence to these measures, they often fail to contain the outbreak [3, 4]. An outbreak sometimes results in the temporary closure of the ICU [5, 6]. The normal measures taken to control an outbreak cause a lot of extra work for the medical and nursing staff. It is therefore important to control outbreaks as soon as possible when they occur, and even more important to apply measures to prevent outbreaks.


Intensive Care Unit Acinetobacter Baumannii Surveillance Culture Infect Control Hosp Sive Care Unit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Monterrubio-Villar J, Gili-Miner M (1999) Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med 27:1794–1799.PubMedCrossRefGoogle Scholar
  2. 2.
    Theaker C, Azadian B, Soni N (2003) The impact of Acinetobacter baumannii in the intensive care unit. Anaesthesia 58:271–274.PubMedCrossRefGoogle Scholar
  3. 3.
    CDC. Guidelines for Preventing Health-Care-Associated Pneumonia. accessed on 25 Feb. 2007Google Scholar
  4. 4.
    CDC. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Accessed on 25 Feb. 2007Google Scholar
  5. 5.
    Humphreys H, Towner KJ (1997) Impact of Acinetobacter spp. in intensive care units in Great Britain and Ireland. J Hosp Infect 37:281–286PubMedCrossRefGoogle Scholar
  6. 6.
    Rashid A, Solomon LK, Lewis HG, Khan K (2006) Outbreak of epidemic methicillin-resistant Staphylococcus aureus in a regional burns unit: management and implications. Burns 32:452–457PubMedCrossRefGoogle Scholar
  7. 7.
    Damjanovic V, Corbell X, van der Spoel JI, van Saene HKF (2005) Outbreaks of infection in intensive care units; usefulness of molecular techniques for outbreak analysis. In: van Saene H, Silvestri L, de la Cal M (eds) Infection control in intensive care units. Springer-Verlag Italia, Milan, pp 247–296CrossRefGoogle Scholar
  8. 8.
    Damjanovic V, van Saene HK (2006) Polyclonal outbreaks: a story not yet told. J Hosp Infect 64:408–409PubMedCrossRefGoogle Scholar
  9. 9.
    Brun-Buisson C, Legrand P, Rauss A, Richard C, Montravers F, Besbes M et al (1989) Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 110:873–881PubMedGoogle Scholar
  10. 10.
    Taylor ME, Oppenheim BA (1991) Selective decontamination of the gastrointestinal tract as an infection control measure. J Hosp Infect 17:271–278PubMedCrossRefGoogle Scholar
  11. 11.
    Thorburn K, Taylor N, Saladi SM, van Saene HK (2006) Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit. Clin Microbiol Infect 12:35–42PubMedCrossRefGoogle Scholar
  12. 12.
    Johnson DR, Love-Dixon MA, Brown WJ, Levine DP, Downes FP, Hall WN (1992) Delayed detection of an increase in resistant Acinetobacter at a Detroit hospital. Infect Control Hosp Epidemiol 13:394–398PubMedGoogle Scholar
  13. 13.
    Husni RN, Goldstein LS, Arroliga AC, Hall GS, Fatica C, Stoller JK et al (1999) Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 115:1378–1382PubMedCrossRefGoogle Scholar
  14. 14.
    Herruzo R, de la C J, Fernandez-Acenero MJ, Garcia-Caballero J (2004) Two consecutive outbreaks of Acinetobacter baumannii 1-a in a burn intensive care unit for adults. Burns 30:419–423PubMedCrossRefGoogle Scholar
  15. 15.
    Yu WL, Cheng HS, Lin HC, Peng CT, Tsai CH (2000) Outbreak investigation of nosocomial Enterobacter cloacae bacteraemia in a neonatal intensive care unit. Scand J Infect Dis 32:293–298PubMedCrossRefGoogle Scholar
  16. 16.
    Cardoso CL, Pereira HH, Zequim JC, Guilhermetti M (1999) Effectiveness of hand-cleansing agents for removing Acinetobacter baumannii strain from contaminated hands. Am J Infect Control 27:327–331PubMedCrossRefGoogle Scholar
  17. 17.
    Silvestri L, Petros AJ, Sarginson RE, de la Cal MA, Murray AE, van Saene HK (2005) Handwashing in the intensive care unit: a big measure with modest effects. J Hosp Infect 59:172–179PubMedCrossRefGoogle Scholar
  18. 18.
    Schaberg DR, Weinstein RA, Stamm WE (1976) Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis 133:363–366PubMedGoogle Scholar
  19. 19.
    Mulin B, Talon D, Viel JF, Vincent C, Leprat R, Thouverez M et al (1995) Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 14:569–576PubMedCrossRefGoogle Scholar
  20. 20.
    Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C et al (1998) The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 158:1127–1132PubMedCrossRefGoogle Scholar
  21. 21.
    Baines PB, Meyer J, de la Fuente JL (2001) Antimicrobial resistance in the intensive care unit: the use of oral non-absorbable antimicrobials may prolong the antibiotic are. Curr Anaesth Crit Care 12:41–47CrossRefGoogle Scholar
  22. 22.
    Weist K, Pollege K, Schulz I, Ruden H, Gastmeier P (2002) How many nosocomial infections are associated with cross-transmission? A prospective cohort study in a surgical intensive care unit. Infect Control Hosp Epidemiol 23:127–132PubMedCrossRefGoogle Scholar
  23. 23.
    Sanchez-Garcia M, Cambronero Galache JA, Lopez DJ, Cerda CE, Rubio BJ, Gomez Aguinaga MA et al (1998) Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial. Am J Respir Crit Care Med 158:908–916PubMedGoogle Scholar
  24. 24.
    Villers D, Espaze E, Coste-Burel M, Giauffret F, Ninin E, Nicolas F et al (1998) Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 129:182–189PubMedGoogle Scholar
  25. 25.
    Lucet JC, Chevret S, Decre D, Vanjak D, Macrez A, Bedos JP et al (1996) Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 22:430–436PubMedGoogle Scholar
  26. 26.
    Simms HH, d’Amico R (1997) Posttraumatic auto-oxidative polymorphonuclear neutrophil receptor injury predicts the development of nosocomial infection. Arch Surg 132:171–172PubMedGoogle Scholar
  27. 27.
    Corbella X, Pujol M, Ayats J, Sendra M, Ardanuy C, Dominguez MA et al. (1996) Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis 23:329–334PubMedGoogle Scholar
  28. 28.
    Podnos YD, Cinat ME, Wilson SE, Cooke J, Gornick W, Thrupp LD (2001) Eradication of multi-drug resistant Acinetobacter from an intensive care unit. Surg Infect (Larchmt ) 2:297–301CrossRefGoogle Scholar
  29. 29.
    Villegas MV, Hartstein AI (2003) Acinetobacter outbreaks, 1977–2000. Infect Control Hosp Epidemiol 24:284–295PubMedCrossRefGoogle Scholar
  30. 30.
    Roberts SA, Findlay R, Lang SD (2001) Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. J Hosp Infect 48:228–232PubMedCrossRefGoogle Scholar
  31. 31.
    Simor AE, Lee M, Vearncombe M, Jones-Paul L, Barry C, Gomez M et al (2002) An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol 23:261–267PubMedCrossRefGoogle Scholar
  32. 32.
    Agusti C, Pujol M, Argerich MJ, Ayats J, Badia M, Dominguez MA et al (2002) Short-term effect of the application of selective decontamination of the digestive tract on different body site reservoir ICU patients colonized by multi-resistant Acinetobacter baumannii. J Antimicrob Chemother 49:205–208PubMedCrossRefGoogle Scholar
  33. 33.
    de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J et al (2003) Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362:1011–1016PubMedCrossRefGoogle Scholar
  34. 34.
    Nouira S, Elatrous S, Boukef R, Boujdaria R, Boussarsar M, Besbes L et al (1998) Effectiveness of selective digestive tract decontamination to control an outbreak of nosocomial pneumonia caused by Pseudomonas aeruginosa in mechanically ventilated patients. Clin Intensive Care 9:180–184CrossRefGoogle Scholar
  35. 35.
    van der Spoel JI, Oudemans-van Straaten HM, Stoutenbeek CP, Bosman RJ, Zandstra DF (2001) Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure-a prospective, double-blind, placebo-controlled trial. Intensive Care Med 27:822–827PubMedCrossRefGoogle Scholar
  36. 36.
    Webster CA, Crowe M, Humphreys H, Towner KJ (1998) Surveillance of an adult intensive care unit for long-term persistence of a multi-resistant strain of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 17:171–176PubMedGoogle Scholar
  37. 37.
    Timsit JF, Garrait V, Misset B, Goldstein FW, Renaud B, Carlet J (1993) The digestive tract is a major site for Acinetobacter baumannii colonization in intensive care unit patients. J Infect Dis 168:1336–1337PubMedGoogle Scholar
  38. 38.
    Scerpella EG, Wanger AR, Armitige L, Anderlini P, Ericsson CD (1995) Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case-control and molecular epidemiologic investigations. Infect Control Hosp Epidemiol 16:92–97PubMedCrossRefGoogle Scholar
  39. 39.
    Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P et al (1995) Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 20:790–796PubMedGoogle Scholar
  40. 40.
    Crowe M, Towner KJ, Humphreys H (1995) Clinical and epidemiological features of an outbreak of acinetobacter infection in an intensive therapy unit. J Med Microbiol 43:55–62PubMedGoogle Scholar
  41. 41.
    Garrouste-Orgeas M, Chevret S, Arlet G, Marie O, Rouveau M, Popoff N et al (1997) Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. Am J Respir Crit Care Med 156:1647–1655PubMedGoogle Scholar
  42. 42.
    Ayats J, Corbella X, Ardanuy C, Dominguez MA, Ricart A, Ariza J et al (1997) Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect 37:287–295PubMedCrossRefGoogle Scholar
  43. 43.
    D’Agata EM, Thayer V, Schaffner W (2000) An outbreak of Acinetobacter baumannii: the importance of cross-transmission. Infect Control Hosp Epidemiol 21:588–591PubMedCrossRefGoogle Scholar
  44. 44.
    Koeleman JG, Parlevliet GA, Dijkshoorn L, Savelkoul PH, Vandenbroucke-Grauls CM (1997) Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: epidemiology and risk factors for acquisition. J Hosp Infect 37:113–123PubMedCrossRefGoogle Scholar
  45. 45.
    Aygun G, Demirkiran O, Utku T, Mete B, Urkmez S, Yilmaz M et al (2002) Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect 52:259–262PubMedCrossRefGoogle Scholar
  46. 46.
    Playford EG, Craig JC, Iredell JR (2007) Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 65:204–211PubMedCrossRefGoogle Scholar
  47. 47.
    Decré D, Gachot B, Lucet JC et al (1998) Clinical and bacteriologic epidemiology of extended-spetrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin Infect Dis 27:834–844PubMedCrossRefGoogle Scholar
  48. 48.
    Pultz NJ, Stiefel U, Donskey CJ (2005) Effects of daptomycin, linezolid and vancomycin on establishment of intestinal colonization with vancomycin-resistant enterococci and extended-spectrum-b-lactamases-producing Klebsiella pneumoniae in mice. Antimicrob Agents Chemother 49:3513–3516PubMedCrossRefGoogle Scholar
  49. 49.
    Al Naiemi N, Heddema ER, Bart A et al (2006) Emergence of multidrug-resistant Gramnegative bacteria during selective decontamination of the digestive tract on an intensive care unit. J Antimicrob Chemother 58:853–856PubMedCrossRefGoogle Scholar
  50. 50.
    Sanchez M, Pizer BP, Alcock SR (2005) Enteral antimicrobials. In: van Saene HKF, Silvestri L, de la Cal MA (eds) Infection control in the intensive care unit, 2nd edn. Springer-Verlag Italia, Milan, pp 171–187Google Scholar
  51. 51.
    Brun-Buisson C, Legrand P, Rauss A et al (1989) Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 110:873–881PubMedGoogle Scholar
  52. 52.
    de la Cal MA, Cerda E, van Saene HK, Garcia-Hierro P, Negro E, Parra ML et al (2004) Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 56:175–183PubMedCrossRefGoogle Scholar
  53. 53.
    Silvestri L, Milanese M, Oblach L, Fontana F, Gregori D, Guerra R et al (2002) Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control 30:391–399PubMedCrossRefGoogle Scholar
  54. 54.
    Silvestri L, van Saene HK, Milanese M, Fontana F, Gregori D, Oblach L et al (2004) Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial. Eur Respir J 23:921–926PubMedCrossRefGoogle Scholar
  55. 55.
    Viviani M, van Saene HK, Dezzoni R, Silvestri L, Di Lenarda R, Berlot G et al (2005) Control of imported and acquired methicillin-resistant Staphylococcus aureus (MRSA) in mechanically ventilated patients: a dose-response study of enteral vancomycin to reduce absolute carriage and infection. Anaesth Intensive Care 33:361–372PubMedGoogle Scholar
  56. 56.
    Damjanovic V, Connolly CM, van Saene HK, Cooke RW, Corkill JE, van Belkum A et al (1993) Selective decontamination with nystatin for control of a Candida outbreak in a neonatal intensive care unit. J Hosp Infect 24:245–259PubMedCrossRefGoogle Scholar
  57. 57.
    Sim ME, Yoo Y, You H, Salminen C, Walther FJ (1988) Prophylactic oral nystatin and fungal infections in very-low-birthweight infants. Am J Perinatol 5:33–36Google Scholar
  58. 58.
    Silvestri L, van Saene HK, Milanese M, Gregori D (2005) Impact of selective decontamination of the digestive tract on fungal carriage and infection: systematic review of randomized controlled trials. Intensive Care Med 31:898–910PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Hans I. van der Spoel
    • 1
  • Rik T. Gerritsen
    • 2
  1. 1.Department of Intensive CareOnze Lieve Vrouwe GasthuisAmsterdamThe Netherlands
  2. 2.Department of Intensive CareMedical Centre LeeuwardenLeeuwardenThe Netherlands

Personalised recommendations